Seagen's breast cancer therapy meets main goal in late-stage study

Pfizer

16/08/2023 13:09

Aug 16 (Reuters) - Seagen  SGEN.O  said on Wednesday its
cancer therapy in combination with Roche's  ROG.S  Kadcyla
helped control disease progression in a late-stage study.       

 (Reporting by Mariam Sunny in Bengaluru; Editing by Maju
Samuel)
 ((Mariam.ESunny@thomsonreuters.com;))